Lastly, the availability of TyG-related indicators for assessing insulin resistance is based on routine clinical care, eliminating the need for specific insulin testing or HIEC, thus making it a readily accessible and cost-effective biomarker with potential clinical applications. Here, INS is linked to Insulin resistance.